Sugarloaf Wealth Management, LLC - INVIVO THERAPEUTICS HLDGS CO ownership

Back to all holdings Add to watchlist

INVIVO THERAPEUTICS HLDGS CO's ticker is and the CUSIP is 46186M605. A total of 16 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
Sugarloaf Wealth Management, LLC ownership history of INVIVO THERAPEUTICS HLDGS CO
ValueSharesWeighting
Q3 2023$10.0%10.0%0.00%–
Q2 2023$10.0%10.0%0.00%–
Q1 2023$1
-50.0%
10.0%0.00%–
Q4 2022$2
-99.8%
10.0%0.00%–
Q3 2022$1,000–10.0%0.00%–
Q2 2022$0–1–0.00%–
 Download
Other shareholders

There were no reported owners of INVIVO THERAPEUTICS HLDGS CO in Q2 2023.

NameSharesValueWeighting ↓
View complete list of INVIVO THERAPEUTICS HLDGS CO shareholders